Healthcare >> CEO Interviews >> October 17, 2003
FREDERICK DRISCOLL was appointed President and Chief Executive Officer
at OXiGENE, Inc. in March 2002. Mr. Driscoll served as OXiGENE's
President of Finance and Operations from October 2000 to March 2002. He
has more than 25 years of experience in Finance and Operations.
Previously, Mr. Driscoll served as the Senior Vice President of Finance
and Operations at Collagenesis Corp. from July 1999 to September 2000
and as Vice President Finance and Chief Financial Officer from September
1996 to July 1999. At Collagenesis Corp., Mr. Driscoll raised $10.2
million in equity financing in a Series B common stock deal. He also
oversaw the leveraged buyout of Instrumentation Laboratory from the
Henley Group. Mr. Driscoll has also served in various senior financial
capacities at Instrumentation laboratory from 1974 to 1996, including
Vice President Finance-Americas for 22 years. Mr. Driscoll received a
Bachelor of Science degree from Bentley College in 1972. Profile
Mr. Driscoll: OXiGENE has been involved in the area of drug discovery
for many years. Over the past two years, we have made
